Healthcare · Diagnostics Research · NASDAQ
| Market cap | $46.43B |
|---|---|
| Trailing P/E | — |
| FCF yield | 0.2% |
| Revenue growth (YoY) | +35.9% |
| EPS growth (YoY) | — |
| FCF/share growth (YoY) | +18.2% |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Diagnostics Research |
Natera, Inc. trades disclosed by members of the US House and Senate under the STOCK Act. See the full Congress trades board →
| Member | Chamber | Trade | Amount | Disclosed |
|---|---|---|---|---|
| Josh Gottheimer | House | Buy | $1,001 - $15,000 | Oct 7, 2025 |
| Josh Gottheimer | House | Buy | $1,001 - $15,000 | Sep 4, 2025 |
| Josh Gottheimer | House | Buy | $1,001 - $15,000 | Dec 3, 2024 |